Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
American Journal of Respiratory Cell and Molecular Biology|March 5, 2005
Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cellsPei-Li Yao, Yi-Chen Lin, Chien-Hsun Wang, et al.JTO Clinical and Research Reports|September 30, 2021
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in TaiwanShang-Gin Wu, Wei-Yu Liao, Kang-Yi Su, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|August 16, 2024
Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failureZong-Han Yao, Wei-Yu Liao, Chin-Yao Yang, et al.Psycho-Oncology|July 30, 2013
Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatmentYun-Hsiang Lee, Yu-Chien Liao, Wei-Yu Liao, et al.American Journal of Respiratory and Critical Care Medicine|December 22, 2007
TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancerChao-Chi Ho, Wei-Yu Liao, Cheng-Yi Wang, et al.European Journal of Cancer (Oxford, England : 1990)|January 12, 2025
Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: A prospective studyHsin-Yi Wang, Wei-Yu Liao, Chao-Chi Ho, et al.Advanced Materials (Deerfield Beach, Fla.)|May 27, 2016
Efficient All-Vacuum Deposited Perovskite Solar Cells by Controlling Reagent Partial Pressure in High VacuumSheng-Yi Hsiao, Hong-Lin Lin, Wei-Hung Lee, et al.Clinical Lung Cancer|February 26, 2018
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer PatientsTing-Hui Wu, Emily Han-Chung Hsiue, Jih-Hsiang Lee, et al.Lung Cancer (Amsterdam, Netherlands)|April 24, 2021
Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancerChia-Lin Hsu, Tzu-Hsiu Tsai, Chun-Kai Huang, et al.BMC Cancer|March 14, 2023
Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitorsChun-Ta Huang, Chih-An Lin, Te-Jen Su, et al.Pageof 9